Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.100
-0.020 (-1.79%)
Aug 1, 2025, 4:00 PM - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $68.14 million as of August 1, 2025. Its market cap has decreased by -64.61% in one year.
Market Cap
68.14M
Enterprise Value
-17.45M
1-Year Change
-64.61%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $68.14M, a decrease of -86.99%. That is a compound annual growth rate of -41.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 68.14M | -26.54% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.57B |
| Johnson & Johnson | 405.06B |
| AbbVie | 338.99B |
| UnitedHealth Group | 238.89B |
| Novo Nordisk | 238.11B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 224.21B |